Industry Experts

Qiuting Hong, Ph.D. is a Director in Biologics Analytical Development with extensive experience in the development, characterization, and manufacturing of biologic therapeutics. Her expertise spans analytical development, CMC analytical strategy, process development, regulatory submissions, and the advancement of antibody-drug conjugates (ADCs) from early research through clinical development. Currently at Exelixis, Inc., she is actively involved in the development of next-generation biologics and ADCs, leveraging innovative analytical approaches to accelerate drug development and support regulatory success. Dr. Hong is passionate about advancing biopharmaceutical science and translating cutting-edge technologies into therapies that address unmet medical needs.